Screener
ClearPoint Neuro CLPT Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from ClearPoint Neuro’s reported figures.
Based on the most recent quarter.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
FAQ
- What is ClearPoint Neuro's debt-to-equity?
- ClearPoint Neuro (CLPT) reported debt-to-equity of 3.4× in Q1 2026.
- How has ClearPoint Neuro's debt-to-equity changed year-over-year?
- ClearPoint Neuro's debt-to-equity increased by 1862.2% year-over-year, from 0.2× to 3.4×.
- What is the long-term trend for ClearPoint Neuro's debt-to-equity?
- Over 5 years (2020 to 2025), ClearPoint Neuro's debt-to-equity has grown at a -27.3% compound annual growth rate (CAGR), from 10.2× to 2.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about ClearPoint Neuro's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude